agilon health, inc.

agilon health, inc.AGLEarnings & Financial Report

NYSE · Health Care · Services-Misc Health & Allied Services, NEC

agilon health, inc. is a U.S.-based healthcare company partnering with primary care providers to deliver value-based care solutions mainly for senior Medicare beneficiaries. It offers administrative support, clinical tools and risk management frameworks to help physicians improve patient outcomes and cut care costs, operating across over 20 U.S. states.

Revenue

$1.5B

Gross Profit

N/A

Operating Profit

$-22.1M

Net Profit

$12.1M

Gross Margin

N/A

Operating Margin

-1.4%

Net Margin

0.8%

YoY Growth

-4.5%

Financial Flow

agilon health, inc. Q1 2025 Financial Summary

agilon health, inc. reported revenue of $1.5B (down 4.5% YoY) for Q1 2025, with a net profit of $12.1M (up 299.7% YoY) (0.8% margin). Cost of goods sold was N/A.

Key Financial Metrics

Total Revenue$1.5B
Net Profit$12.1M
Gross MarginN/A
Operating Margin-1.4%
Report PeriodQ1 2025

Revenue Breakdown

agilon health, inc. Q1 2025 revenue of $1.5B breaks down across 2 segments, led by Medical Services at $1.5B (99.8% of total).

SegmentRevenue% of Total
Medical Services$1.5B99.8%
Other Operating$2.9M0.2%

agilon health, inc. Revenue by Segment — Quarterly Trend

agilon health, inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Medical Services and Other Operating) has evolved quarter over quarter.

SegmentQ4 2025Q3 2025Q2 2025Q1 2025
Medical Services$1.6B$1.4B$1.4B$1.5B
Other Operating$2.5M$2.9M$2.9M$2.9M

agilon health, inc. Annual Revenue by Year

agilon health, inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $5.9B).

YearAnnual Revenue
2025$5.9B
2024$6.1B
2023$4.3B
2022$2.4B

agilon health, inc. Quarterly Revenue & Net Profit History

agilon health, inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q4 2025$1.6B+3.1%$-188.9M-12.0%
Q3 2025$1.4B-1.1%$-110.2M-7.7%
Q2 2025$1.4B-5.9%$-104.4M-7.5%
Q1 2025$1.5B-4.5%$12.1M0.8%
Q4 2024$1.5B+44.2%$-105.8M-6.9%
Q3 2024$1.5B+27.6%$-117.6M-8.1%
Q2 2024$1.5B+38.7%$-30.7M-2.1%
Q1 2024$1.6B+52.2%$-6.1M-0.4%

Income Statement

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Revenue$1.60B$1.48B$1.45B$1.52B$1.53B$1.39B$1.44B$1.57B
YoY Growth52.2%38.7%27.6%44.2%-4.5%-5.9%-1.1%3.1%

Balance Sheet

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Assets$2.32B$2.16B$2.09B$1.73B$1.93B$1.71B$1.60B$1.27B
Liabilities$1.63B$1.49B$1.52B$1.26B$1.43B$1.30B$1.29B$1.14B
Equity$689.3M$676.6M$574.9M$471.0M$500.3M$408.9M$306.1M$126.7M

Cash Flow

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Operating CF$-47.8M$-18.7M$-7.7M$16.4M$-32.0M$-35.1M$-18.2M$-20.5M